Compare ARK Genomic Revolution ETF (ARKG) vs Ferrari NV (RACE) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Ferrari NV — how do they compare? ARK Genomic Revolution ETF trades at $40.83, while Ferrari NV trades at $376.2 (market cap $66.31B). The key difference: Ferrari NV pays a 1.12% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Ferrari NV nearer its low. Which is the better fit depends on your goals.
| ARKG | RACE | |
|---|---|---|
Sector | Sector/Thematic | Consumer Cyclical |
52-Week High | $43.57 | $517.65 |
52-Week Low | $23.09 | $314.63 |
Market Cap | — | $66.31B |
Enterprise Value | — | $67.52B |
Dividend Yield | — | 1.12% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Ferrari (RACE) trades at $376.64, up 0.53% with bullish technical signals and strong fundamentals. The stock shows consistent earnings beats, with Q1 2026 EPS of $2.73 exceeding expectations. Revenue grew to $7.15B in 2025, supported by a 22.19% net margin and 41.96% ROE. Recent news highlights include a new EV model launch and ongoing share buybacks, while technical indicators point to support near $372 and resistance at $377.
The outlook remains positive with a consensus price target of $467.50, implying 24% upside. Key risks include execution challenges with new electric vehicles and economic sensitivity. Analyst sentiment is strongly bullish (72% buy ratings), but investors should monitor competitive pressures and margin sustainability amid hybrid transition efforts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Ferrari NV
Ferrari engineers and manufactures some of the world's most expensive exotic sports cars. The Ferrari brand is synonymous with Formula One racing, exclusivity, Italian design, and state-of-the-art technology. Ferrari also has a captive finance company that provides funding for dealers and clients.
Read more on RACE →
